Repare Therapeutics Inc (RPTX)

02:51 AM

Repare Therapeutics Stock Hits 52-Week Low at $0.98 Amid Market Challenges - Investing.com

02:51 AM

Apr 03, 2025

Petri Dish: Vertex halts type 1 diabetes trial; Watertown manufacturer sold - The Business Journals

Apr 03, 2025

Mar 31, 2025

Repare Therapeutics Appoints Steve Forte CEO - citybiz

Mar 31, 2025

Mar 31, 2025

Repare Therapeutics appoints CFO as new CEO - MSN

Mar 31, 2025

Mar 31, 2025

Repare Therapeutics Appoints Steve Forte as CEO to Succeed Lloyd Segal - MarketScreener

Mar 31, 2025

Mar 31, 2025

Repare Therapeutics Announces Leadership Changes in 2025 - TipRanks

Mar 31, 2025

Mar 31, 2025

Repare Therapeutics Names Forte as President, CEO - MarketWatch

Mar 31, 2025

Mar 31, 2025

Repare Therapeutics CEO Lloyd Segal resigns, Steve Forte succeeds - TipRanks

Mar 31, 2025

Mar 31, 2025

Repare's New CEO Takes Helm With 3 Clinical Trial Readouts Coming in 2025 - Stock Titan

Mar 31, 2025

Mar 31, 2025

Layoff Tracker: Arbutus Cuts 57% of Workforce - BioSpace

Mar 31, 2025

Mar 27, 2025

Cathie Wood’s ARK trims Illumina, exits Repare Therapeutics stock - Investing.com

Mar 27, 2025

Mar 25, 2025

Repare Therapeutics stock hits 52-week low at $1.05 By Investing.com - Investing.com Australia

Mar 25, 2025

Mar 25, 2025

Repare Therapeutics stock hits 52-week low at $1.05 - Investing.com

Mar 25, 2025

Mar 22, 2025

Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen - Benzinga

Mar 22, 2025

Mar 20, 2025

Fierce Biotech Layoff Tracker 2025: Cargo lays off 90% of staff; Empress halves workforce - Fierce Biotech

Mar 20, 2025

Mar 15, 2025

Repare therapeutics’ chief medical officer sells shares for $4,099 By Investing.com - Investing.com Australia

Mar 15, 2025

Mar 15, 2025

Cathie Wood's Ark Invest Continues To Offload UiPath, Roblox: Loads Up On GitLab, Ibotta - Benzinga

Mar 15, 2025

Mar 14, 2025

Repare therapeutics’ chief scientific officer sells $6,396 in shares - Investing.com India

Mar 14, 2025

Mar 14, 2025

Repare therapeutics’ chief scientific officer sells $6,396 in shares By Investing.com - Investing.com South Africa

Mar 14, 2025

Mar 14, 2025

Repare therapeutics CEO Segal Lloyd Mitchell sells $24,144 in shares By Investing.com - Investing.com South Africa

Mar 14, 2025

Mar 14, 2025

Repare therapeutics CEO Segal Lloyd Mitchell sells $24,144 in shares - Investing.com

Mar 14, 2025

Mar 14, 2025

Repare Therapeutics CEO Sells Shares to Cover Tax Obligations - TradingView

Mar 14, 2025

Mar 11, 2025

HC Wainwright Issues Pessimistic Forecast for Repare Therapeutics (NASDAQ:RPTX) Stock Price - MarketBeat

Mar 11, 2025

Mar 11, 2025

What Makes Repare Therapeutics (RPTX) a New Buy Stock - Yahoo Finance

Mar 11, 2025

Mar 07, 2025

Repare Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Bluefield Daily Telegraph

Mar 07, 2025

Mar 07, 2025

Repare Therapeutics stock target cut to $5 at H.C. Wainwright - Investing.com India

Mar 07, 2025

Mar 07, 2025

Repare Therapeutics stock target cut to $5 at H.C. Wainwright By Investing.com - Investing.com Canada

Mar 07, 2025

Mar 07, 2025

Strategic Pipeline Focus and Financial Stability Support Buy Rating for Repare Therapeutics - TipRanks

Mar 07, 2025

Mar 07, 2025

symbol__ Stock Quote Price and Forecast - CNN

Mar 07, 2025

Mar 07, 2025

Repare Therapeutics (NASDAQ:RPTX) Announces Quarterly Earnings Results, Beats Estimates By $0.10 EPS - MarketBeat

Mar 07, 2025

Mar 07, 2025

New Hires at Repare Get Stock Options as Share Price Shows 67% Drop - Stock Titan

Mar 07, 2025

Mar 04, 2025

Here's Why We're Watching Repare Therapeutics' (NASDAQ:RPTX) Cash Burn Situation - Yahoo Finance

Mar 04, 2025

Mar 03, 2025

Repare Therapeutics Focuses on Clinical Trials Amid Restructuring - TipRanks

Mar 03, 2025

Mar 03, 2025

Repare Therapeutics Restructures and Focuses on Key Clinical Trials - MSN

Mar 03, 2025

Mar 03, 2025

Repare Therapeutics Provides Business and Clinical Update and Reports Fourth Quarter and Full Year 2024 Financial Results - CRISPR Medicine News

Mar 03, 2025

Mar 03, 2025

Repare Therapeutics anticipates key trial results by late 2025 - Investing.com Canada

Mar 03, 2025